Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical testosterone cream for cancer-related fatigue in advanced cancer
ACTRN12624000345583Phase 3Completed
- Sponsor
- University of Technology Sydney
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in cancer-related fatigue (CRF) comparing Topical testosterone with Placebo cream (2 arms). Primary endpoint: Feasibility for future definitive Phase III trial. Started Jun 2024; status: completed.
02
Drugs
testosterone
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on ACTRN12624000345583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000345583.